Home » Topics » BioWorld Science

BioWorld Science
RSS

New AAV gene therapy for mucopolysaccharidosis IVA

Sep. 6, 2019

Bristol-Myers Squibb describes preclinical profile of apelin receptor agonist BMS-986224

Sep. 6, 2019

Phase III CheckMate-548 study does not meet one of its primary endpoints

Sep. 6, 2019

Patient enrollment ongoing in phase I study of Debio-0123

Sep. 6, 2019

FDA grants IND approval for HH-2710

Sep. 6, 2019

Circulating galectin-1 as a predictive biomarker of CAD and MACE in patients with stable angina

Sep. 6, 2019

CAD-1883 demonstrates promising safety in phase I study

Sep. 6, 2019

Potent AXL kinase inhibitor with promising in vitro and in vivo biological activity

Sep. 6, 2019

An organoid model for prenatal brain development

Sep. 6, 2019

Dystrophy mutation protects cells from HIV infection

Sep. 6, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...